By binding to GLP-1 receptors in the hypothalamus, they reduce appetite and promote satiety, leading to significant weight reduction in clinical trialswith newer agents achieving approximately 15% weight loss in obesity without diabetes (semaglutide) and up to 21% (tirzepatide), with somewhat lower reductions typically seen in patients with type 2 diabetes
Owing to this large age gap, the beneficial effect of dexamethasone may have been partly masked in the older adult cohort
GLP-1 drugs suppress appetite and weight and can drop blood glucose and blood pressure, potentially making surgery outcomes better in the long run
At Genesis Lifestyle Medicine, GLP-1 therapy in Grapevine is part of a customized approach designed to support weight-management goals without relying solely on willpower
Theyre all over the news and social media right nowbut what do they actually do
Holler N, Ruseska I, Schachner-Nedherer A-L, et al